Covered recipient · General Payments record
KAREN PARHAM
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Primary Care
General Payments · PY2023–2024
$805.50
- Reported across 46 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $354.91 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $173.50 | 13 |
| Novo Nordisk AS | $64.12 | 4 |
| Acerta Pharma LLC | $28.69 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $21.79 | 1 |
| Astellas Pharma US Inc | $20.74 | 1 |
| Xeris Pharmaceuticals, Inc. | $17.69 | 1 |
| Exact Sciences Corporation | $14.67 | 1 |
| Lilly USA, LLC | $13.71 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.73 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107785603 | CMS |
| ABBVIE INC. | $11.47 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107785607 | CMS |
| ABBVIE INC. | $4.22 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107785612 | CMS |
| ABBVIE INC. | $7.86 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107785617 | CMS |
| ABBVIE INC. | $6.23 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107785622 | CMS |
| ABBVIE INC. | $28.97 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107785626 | CMS |
| ABBVIE INC. | $9.29 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107785631 | CMS |
| ABBVIE INC. | $4.31 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107785635 | CMS |
| ABBVIE INC. | $5.64 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107785640 | CMS |
| ABBVIE INC. | $33.54 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107785644 | CMS |
| ABBVIE INC. | $18.86 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107785649 | CMS |
| ABBVIE INC. | $3.09 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107785654 | CMS |
| ABBVIE INC. | $17.29 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107785658 | CMS |
| Astellas Pharma US Inc | $20.74 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139501652 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.12 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105757583 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.57 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104722333 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $21.79 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086277934 | CMS |
| Exact Sciences Corporation | $14.67 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114822670 | CMS |
| Lilly USA, LLC | $13.71 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135724547 | CMS |
| Novo Nordisk Inc | $16.23 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100507367 | CMS |
| Novo Nordisk Inc | $14.60 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100269182 | CMS |
| Novo Nordisk Inc | $19.16 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100317612 | CMS |
| Novo Nordisk Inc | $14.13 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100556173 | CMS |
| Xeris Pharmaceuticals, Inc. | $17.69 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144630439 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.